Quantcast

Latest Humanized antibody Stories

2010-09-02 04:35:01

Tokyo, Sept 2, 2010 - (JCN Newswire) - Eisai Co., Ltd. announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease.

2010-08-12 14:50:00

BURLINGAME, Calif., Aug. 12 /PRNewswire/ -- Epitomics, Inc.

2010-08-11 07:00:00

INCLINE VILLAGE, Nev., Aug. 11 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.

2010-07-01 13:52:00

BOSTON, July 1 /PRNewswire/ -- China PharmaHub Corp. ("PharmaHub"), announced today that it has entered into a definitive agreement with Dr. David Weaver and Dr. Michael Rynkiewicz. In addition, PharmaHub contemplates merging with World Wide Relics, Inc.

2010-06-03 16:00:00

MISSISSAUGA, ON, June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today announced the appointment of Dr. Nick Glover to the newly created position of President and Chief Operating Officer. Dr.

2010-05-04 07:30:00

INCLINE VILLAGE, Nev., May 4 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P.

2010-03-18 13:49:06

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies – the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.

2010-03-16 07:30:00

INCLINE VILLAGE, Nev., March 16 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 9, 2010 at 9:00a.m. Pacific Time for all stockholders of record on April 15, 2010.

2010-03-03 07:30:00

INCLINE VILLAGE, Nev., March 3 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.